%A Xie Xiaojuan, Tong Zhongsheng %T |Medical therapy of bone metastases of breast cancer %0 Journal Article %D 2015 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2015.12.010 %P 920-923 %V 42 %N 12 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9845.shtml} %8 2015-12-08 %X Approximately 70% advanced breast cancer will develop bone metastases. Bone metastases can cause a series of complications such as skeletalrelated events, seriously affecting the quality of life of the patients. Therefore, it is very important to choose the reasonable and effective treatments. Bisphosphonates are the standard treatments of bone metastatic breast cancer, denosumab may also be a reasonable alternative to bisphosphonates in the near future, while chemotherapy, endocrinotherapy and targeted therapy are the basic treatments of advanced breast cancer, combined use of various treatments will get the best efficacy.